U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07228039) titled 'ESP Blocks for Posterior Spinal Fusion' on Nov. 12.
Brief Summary: This prospective randomized double-blind study evaluates the efficacy of erector spinae plane (ESP) blocks on postoperative pain in patients undergoing cervical or lumbar posterior spinal fusion. Patients will receive either 0.5% bupivacaine plus liposomal bupivacaine or 0.5% plain bupivacaine. Outcomes include opioid consumption over 72 hours, pain scores, length of stay, and time to ambulation.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Postoperative Pain
Intervention:
DRUG: ESP Block with Bupivacaine
Cervical and lumbar ESP blocks pe...